Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

George Francis Murphy, M.D.

Co-Author

This page shows the publications co-authored by George Murphy and Martin Mihm.
Connection Strength

1.895
  1. Recognition and evaluation of cytological dysplasia in acquired melanocytic nevi. Hum Pathol. 1999 May; 30(5):506-12.
    View in: PubMed
    Score: 0.203
  2. Malignant melanoma in situ: an oxymoron whose time has come. Hum Pathol. 1998 Jan; 29(1):6-7.
    View in: PubMed
    Score: 0.185
  3. Novel genetic mutations in a sporadic port-wine stain. JAMA Dermatol. 2014 Dec; 150(12):1336-40.
    View in: PubMed
    Score: 0.150
  4. Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors. Mod Pathol. 2014 Sep; 27(9):1193-202.
    View in: PubMed
    Score: 0.141
  5. SOX2 contributes to melanoma cell invasion. Lab Invest. 2012 Mar; 92(3):362-70.
    View in: PubMed
    Score: 0.122
  6. Histologic reporting of malignant melanoma. Monogr Pathol. 1988; (30):79-93.
    View in: PubMed
    Score: 0.093
  7. Capsule dermatopathology: clinicopathologic types of malignant melanoma--relevance to biologic behavior and diagnostic surgical approach. J Dermatol Surg Oncol. 1985 Jul; 11(7):674-82.
    View in: PubMed
    Score: 0.078
  8. Depletion and repopulation of epidermal dendritic cells after allogeneic bone marrow transplantation in humans. J Invest Dermatol. 1985 Mar; 84(3):210-4.
    View in: PubMed
    Score: 0.076
  9. In situ identification of T6-positive cells in normal human dermis by immunoelectron microscopy. Br J Dermatol. 1983 Apr; 108(4):423-31.
    View in: PubMed
    Score: 0.067
  10. Distribution of cell surface antigens in histiocytosis X cells. Quantitative immunoelectron microscopy using monoclonal antibodies. Lab Invest. 1983 Jan; 48(1):90-7.
    View in: PubMed
    Score: 0.066
  11. Microvascular injury in lymphomatoid granulomatosis involving the skin. An ultrastructural study. Arch Dermatol. 1981 Dec; 117(12):804-8.
    View in: PubMed
    Score: 0.061
  12. Characterization of Langerhans cells by the use of monoclonal antibodies. Lab Invest. 1981 Nov; 45(5):465-8.
    View in: PubMed
    Score: 0.060
  13. 5-Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms. J Cutan Pathol. 2017 Mar; 44(3):249-255.
    View in: PubMed
    Score: 0.044
  14. Decreased tumor-infiltrating lymphocytes in nodular melanomas compared with matched superficial spreading melanomas. Melanoma Res. 2016 10; 26(5):524-7.
    View in: PubMed
    Score: 0.043
  15. Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma. Oncotarget. 2015 Nov 10; 6(35):37995-8004.
    View in: PubMed
    Score: 0.040
  16. Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth. Cell. 2015 Sep 10; 162(6):1242-56.
    View in: PubMed
    Score: 0.039
  17. Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas. Clin Epigenetics. 2015; 7:59.
    View in: PubMed
    Score: 0.039
  18. Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant Potential. J Invest Dermatol. 2015 Jul; 135(7):1849-1862.
    View in: PubMed
    Score: 0.038
  19. Bevacizumab plus ipilimumab in patients with metastatic melanoma. Cancer Immunol Res. 2014 Jul; 2(7):632-42.
    View in: PubMed
    Score: 0.036
  20. Loss of 5-hydroxymethylcytosine correlates with increasing morphologic dysplasia in melanocytic tumors. Mod Pathol. 2014 Jul; 27(7):936-44.
    View in: PubMed
    Score: 0.035
  21. CXCR4 pathway associated with family history of melanoma. Cancer Causes Control. 2014 Jan; 25(1):125-32.
    View in: PubMed
    Score: 0.035
  22. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell. 2012 Sep 14; 150(6):1135-46.
    View in: PubMed
    Score: 0.032
  23. Progression of cutaneous melanoma: implications for treatment. Clin Exp Metastasis. 2012 Oct; 29(7):775-96.
    View in: PubMed
    Score: 0.032
  24. Dysplastic nevus: a formal histogenetic precursor of malignant melanoma. Monogr Pathol. 1988; (30):10-8.
    View in: PubMed
    Score: 0.023
  25. Erythema nodosum leprosum: nature and extent of the cutaneous microvascular alterations. J Am Acad Dermatol. 1986 Jan; 14(1):59-69.
    View in: PubMed
    Score: 0.020
  26. Linear IgA bullous dermatosis v dermatitis herpetiformis. Quantitative measurements of dermoepidermal alterations. Arch Dermatol. 1984 Mar; 120(3):324-8.
    View in: PubMed
    Score: 0.018
  27. Histiocytosis-X: in situ characterization of cutaneous infiltrates with monoclonal antibodies. Am J Clin Pathol. 1983 Mar; 79(3):294-300.
    View in: PubMed
    Score: 0.017
  28. Biochemical studies of immune complexes. II. Purification of immune complexes from sera of patients with malignant melanoma. Clin Immunol Immunopathol. 1983 Mar; 26(3):318-26.
    View in: PubMed
    Score: 0.017
  29. Lymphocytes and necrosis of the cutaneous microvasculature in malignant atrophic papulosis: a refined light microscope study. J Am Acad Dermatol. 1982 Nov; 7(5):620-30.
    View in: PubMed
    Score: 0.016
  30. Neutrophilic eccrine hidradenitis. A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy. Arch Dermatol. 1982 Apr; 118(4):263-6.
    View in: PubMed
    Score: 0.016
  31. T cell subsets and Langerhans cells in lichen planus: in situ characterization using monoclonal antibodies. Br J Dermatol. 1981 Dec; 105(6):617-22.
    View in: PubMed
    Score: 0.015
  32. A new immunologic marker for human Langerhans cells. N Engl J Med. 1981 Mar 26; 304(13):791-2.
    View in: PubMed
    Score: 0.014
  33. Oral warty dyskeratoma. Arch Dermatol. 1980 Aug; 116(8):929-31.
    View in: PubMed
    Score: 0.014
  34. Location of HLA-A,B,C antigens in dendritic cells of normal human skin: an immunoelectron microscopic study. J Invest Dermatol. 1983 Jun; 80(6):481-4.
    View in: PubMed
    Score: 0.004
  35. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study. J Invest Dermatol. 1983 Feb; 80(2):100-3.
    View in: PubMed
    Score: 0.004
  36. Ultrastructural and x-ray microanalytical observations of minocycline-related hyperpigmentation of the skin. J Invest Dermatol. 1981 Sep; 77(3):264-71.
    View in: PubMed
    Score: 0.004
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.